2/28/2024  10:57:06 AM Chg. +0.050 Volume Bid9:59:09 PM Ask9:59:09 PM Market Capitalization Dividend Y. P/E Ratio
36.340EUR +0.14% 30
Turnover: 1,090.200
-Bid Size: - -Ask Size: - 10.57 bill.EUR 3.11% 15.66

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Helen Giza
Management board
Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.95%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49 (0) 6172 609-2525
IR Fax: +49 (0) 6172 609-2301
IR e-mail: ir@fmc-ag.com

Company calendar

CW 12 | 3/22/2024 4th Quarter/Annual Report
CW 19 | 5/10/2024 Interim Report 1st Quarter/3 Months
CW 20 | 5/16/2024 General Shareholder Meeting
CW 31 | 8/2/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 11/8/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Institutional investors
 
61.00%
Else-Kröner-Fresenius-Stiftung
 
27.00%
Retail holdings
 
8.00%
Not identified
 
4.00%